Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Nutrition
Published in: European Journal of Nutrition 5/2007

01-08-2007 | ORIGINAL CONTRIBUTION

Dietary omega-3-polyunsaturated fatty acids prevent the development of metastases of colon carcinoma in rat liver

Authors: Carsten N. Gutt, Lars Brinkmann, Arianeb Mehrabi, Hamidreza Fonouni, Beat P. Müller-Stich, Gregor Vetter, Jürgen M. Stein, Peter Schemmer, Markus W. Büchler

Published in: European Journal of Nutrition | Issue 5/2007

Login to get access

Abstract

Background

Fish oil consisting of omega-3 polyunsaturated fatty acids (PUFA) seems to reduce the incidence of colon cancer. The effect of PUFAs on metastasis of colon carcinoma is still unclear.

Aim

The study was designed to examine the effects of a diet rich in omega-3-PUFAs on a model of colorectal metastasis.

Methods

Thirthy animals (WAG/Rij) were randomly assigned to receive an omega-3 diet or a control diet to evaluate their effect on tumor growth. The target male rats (WAG/Rij) were fed a diet containing 15% omega-3-fatty acids three days before and 28 days after intervention and the control rats received 15% coconut oil at the same time points. CC 531 cells, a moderately differentiated colon adenocarcinoma, were injected into the spleen of each rat. After 28 days of diet, animals were sacrificed. The tumor growth was evaluated macroscopically and microscopically in liver tissue. The tissue was examined after immunostaining and the use of monoclonal antibodies.

Results

PUFAs decreased the index of tumor load from 1.54 in the controls to 0.79 in the treatment group (P = 0.036). While 69.2% of the control animals were tumor positive, only 21.4% of the target animals showed tumor after omega-3-fatty acid (P < 0.05).

Conclusion

We could show that omega-3-fatty acids may decrease malignant metastatic tumor growth in the liver.
Literature
1.
Stehr SN, Heller AR (2006) Omega-3 fatty acid effects on biochemical indices following cancer surgery. Clinica chimica acta. Int J Clin Chem 373:1–8
2.
Bartsch H, Nair J, Owen R (1999) Dietary polyunsaturated fatty acids and cancer of the breast and colorectum: emerging evidence for their role as risk modi.ers. Carcinogenesis 20:2209–2218CrossRef
3.
Eastwood G (1996) Pharmacologic prevention of colonic neoplasms. E.ects of calcium, vitamins, omega fatty acids and nonsteroidal anti-in.ammatory drugs. Dig Dis Sci 14:119–128CrossRef
4.
Reddy B (1994) Chemoprevention of colon cancer by dietary fatty acids. Cancer Metastasis Rev 13:285–302CrossRef
5.
Begin ME, Ells G, Das UN (1986) Selected fatty acids as possible intermediates for selective cytotoxic activity of anticancer agents involving oxygen radicals. Anticancer Res 6:291–295
6.
Ells GW, Chisholm KA, Simmons VA, Horrobin DF (1996) Vitamin E blocks the cytotoxic effect of gamma-linolenic acid when administered as late as the time of onset of cell death–insight into the mechanism of fatty acid induced cytotoxicity. Cancer Lett 98:207–211CrossRef
7.
Hansen PMB, McEntee MF, Chiu CH et al. (2000) Antagonism of arachidonic acid is linked to antitumorigenic effect of dietary eicosapentaenoic acid in APCMin/+ Mice. J Nutr 130:1153–1158
8.
Kubota T, Koshizuka K, Williamson EA, Asou H, Said JW, Holden S, Miyoshi I, Koeffler HP (1998) Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res 58:3344–3352
9.
German NS, Johanning GL (1997) Eicosapentaenoic acid and epidermal growth factor modulation of human breast cancer cell adhesion. Cancer Lett 118:95–100CrossRef
10.
Reddy B, Maruyama H (1986) E.ect of dietary .sh oil on azoxymethane induced colon carcinogenesis in male F344 rats. Cancer Res 46:3367–3370
11.
Cannizzo F Jr., Broitman SA (1989) Postpromotional effects of dietary marine or safflower oils on large bowel or pulmonary implants of CT-26 in mice. Cancer Res 49:4289–4294
12.
Sakaguchi M, Minoura T, Hiramatsu Y, Takada H, Yamamura M, Hioki K, Yamamoto M (1986) E.ects of dietary saturated and unsaturated fatty acids on fecal bile acids and colon carcinogenesis induced by azoxymethane in rats. Cancer Res 46:61–65
13.
Latham P, Lund E, Johnson I (1999) Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon. Carcinogenesis 20:645–650CrossRef
14.
Latham P, Lund EK, Brown JC, Johnson IT (2001) Effects of cellular redox balance on induction of apoptosis by eicosapentaenoic acid in HT29 colorectal adenocarcinoma cells and rat colon in vivo. Gut 49:97–105CrossRef
15.
Iwamoto S, Senzaki H, Kiyozuka Y, Ogura E, Takada H, Hioki K, Tsubura A (1998) E.ects of fatty acids on liver metastasis of ACL-15 rat colon cancer cells. Nutr Cancer 31:143–150
16.
Yang S, Morita I, Murota S (1998) Eicosapentaenoic acid attenuates vascular endothelial growth factor induced proliferation via inhibiting endothelial cells. J Cell Physiol 176:342–349CrossRef
17.
Iigo M, Nakagawa T, Ishikawa C, Iwahori Y, Asamoto M, Yazawa K, Araki E, Tsuda H (1997) Inhibitory effects of docosahexaenoic acid on colon carcinoma 26 metastasis to the lung. Br J Cancer 75:650–655
18.
Suzuki I, Iigo M, Ishikawa C, Kuhara T, Asamoto M, Kunimoto T, Moore MA, Yazawa K, Araki E, Tsuda H (1997) Inhibitory effects of oleic and docosahexaenoic acids on lung metastasis by colon-carcinoma-26 cells are associated with reduced matrix metalloproteinase-2 and -9 activities. Int J Cancer 73:607–612CrossRef
19.
Griffini P, Fehres O, Klieverik L, Vogels IM, Tigchelaar W, Smorenburg SM, Van Noorden CJ (1998) Dietary omega-3 polyunsaturated fatty acids promote colon carcinoma metastasis in rat liver. Cancer Res 58:3312–3319
20.
Bohle AS, Kalthoff H (1999) Molecular mechanisms of tumor metastasis and angiogenesis. Langenbecks Arch Surg 384:133–140CrossRef
21.
Haier J, Nasralla M, Nicolson GL (2000) Cell surface molecules and their prognostic values in assessing colorectal carcinomas. Ann Surg 231:11–24CrossRef
22.
Kinsella AR, Green B, Lepts GC, Hill CL, Bowie G, Taylor BA (1993) The role of the cell-cell adhesion molecule E-cadherin in large bowel tumour cell invasion and metastasis. Br J Cancer 67:904–909
23.
Maurer CA, Friess H, Kretschmann B, Wildi S, Muller C, Graber H, Schilling M, Buchler MW (1998) Over-expression of ICAM-1, VCAM-1 and ELAM-1 might influence tumor progression in colorectal cancer. Int J Cancer 79:76–81CrossRef
24.
Mulder JW, Kruyt PM, Sewnath M, Oosting J, Seldenrijk CA, Weidema WF, Offerhaus GJ, Pals ST (1994) Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 344:1470–1472CrossRef
25.
Jiang WG (1996) Cell adhesion molecules in the formation of liver metastasis. J Hepatobiliary Surg 5:375–382CrossRef
26.
Bouvy ND, Marquet RL, Jeekel H, Bonjer HJ (1996) Impact of gas (less) laparoscopy and laparotomy on peritoneal tumor growth and abdominal wall metastases. Ann Surg 224:694–700; discussion 700–691CrossRef
27.
Danesch U, Weber PC, Sellmayer A (1996) Differential effects of n-6 and n-3 polyunsaturated fatty acids on cell growth and early gene expression in Swiss 3T3 fibroblasts. J Cell Physiol 168:618–624CrossRef
28.
Falconer JS, Ross JA, Fearon KC, Hawkins RA, O’Riordain MG, Carter DC (1994) Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines. Br J Cancer 69:826–832
29.
O’Connor TP, Roebuck BD, Peterson F, Campbell TC (1985) Effect of dietary intake of fish oil and fish protein on the development of L-azaserine-induced preneoplastic lesions in the rat pancreas. J Natl Cancer Inst 75:959–962
30.
Rose DP, Connolly JM, Rayburn J (1995) Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice. J Natl Cancer Inst 87:587–592CrossRef
31.
Wu M, Harvey KA, Ruzmetov N, Welch ZR, Sech L, Jackson K, Stillwell W, Zaloga GP, Siddiqui RA (2005) Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway. Int J Cancer 117:340–348CrossRef
32.
Calder PC, Davis J, Yaqoob P, Pala H, Thies F, Newsholme EA (1998) Dietary fish oil suppresses human colon tumour growth in athymic mice. Clin Sci (Lond) 94:303–311
33.
Anti M, Armelao F, Marra G et al. (1994) Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas. Gastroenterology 107:1709–1718
34.
Hayashi Y, Fukushima S, Kishimoto S, Kawaguchi T, Numata M, Isoda Y, Hirano J, Nakano M (1992) Anticancer effects of free polyunsaturated fatty acids in an oily lymphographic agent following intrahepatic arterial administration to a rabbit bearing VX-2 tumor. Cancer Res 52:400–405
35.
Lindner MA (1991) A fish oil diet inhibits colon cancer in mice. Nutr Cancer 15:1–11CrossRef
36.
Noguchi M, Minami M, Yagasaki R, Kinoshita K, Earashi M, Kitagawa H, Taniya T, Miyazaki I (1997) Chemoprevention of DMBA-induced mammary carcinogenesis in rats by low-dose EPA and DHA. Br J Cancer 75:348–353
37.
Calviello G, Palozza P, Piccioni E, Maggiano N, Frattucci A, Franceschelli P, Bartoli GM (1998) Dietary supplementation with eicosapentaenoic and docosahexaenoic acid inhibits growth of Morris hepatocarcinoma 3924A in rats: effects on proliferation and apoptosis. Int J Cancer 75:699–705CrossRef
38.
Heukamp I, Kilian M, Gregor JI, Kiewert C, Schimke I, Kristiansen G, Walz MK, Jacobi CA, Wenger FA (2006) Impact of polyunsaturated fatty acids on hepato-pancreatic prostaglandin and leukotriene concentration in ductal pancreatic cancer – is there a correlation to tumour growth and liver metastasis? Prostag Leukotr Ess 74:223–233CrossRef
39.
Ambs S, Hussain S, Harris C (1997) Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J 11:443–448
40.
Cooke J, Losordo D (2002) Nitric oxide and angiogenesis. Circulation 105:2133–2135CrossRef
41.
Lala P, Chakraborty C (2001) Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol 2:149–156CrossRef
42.
Weber C, Erl W, Pietsch A, Danesch U, Weber PC (1995) Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor-alpha. Arterioscl Throm Vas 15:622–628
43.
De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby P (1994) The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscl Thromb Vas 14:1829–1836
44.
Martin D, Meckling-Gill KA (1996) Omega-3 polyunsaturated fatty acids increase purine but not pyrimidine transport in L1210 leukaemia cells. Biochem J 315 (Pt 1):329–333
45.
Beck SA, Smith KL, Tisdale MJ (1991) Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover. Cancer Res 51:6089–6093
46.
Cheng J, Ogawa K, Kuriki K, Yokoyama Y, Kamiya T, Seno K, Okuyama H, Wang J, Luo C, Fujii T, Ichikawa H, Shirai T, Tokudome S (2003) Increased intake of n-3 polyunsaturated fatty acids elevates the level of apoptosis in the normal sigmoid colon of patients polypectomized for adenomas/tumors. Cancer Lett 193:17–24CrossRef
47.
Hofmanova J, Vaculova A, Lojek A, Kozubik A (2004) Interaction of polyunsaturated fatty acids and sodium butyrate during apoptosis in HT-29 human colon adenocarcinoma cells. Eur J Nutr:1–12
Metadata
Title
Dietary omega-3-polyunsaturated fatty acids prevent the development of metastases of colon carcinoma in rat liver
Authors
Carsten N. Gutt
Lars Brinkmann
Arianeb Mehrabi
Hamidreza Fonouni
Beat P. Müller-Stich
Gregor Vetter
Jürgen M. Stein
Peter Schemmer
Markus W. Büchler
Publication date
01-08-2007
Publisher
D. Steinkopff-Verlag
Published in
European Journal of Nutrition / Issue 5/2007
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-007-0662-y

Other articles of this Issue 5/2007

European Journal of Nutrition 5/2007 Go to the issue

ORIGINAL CONTRIBUTION

Iodine prophylaxis—the protective factor against stomach cancer in iodine deficient areas

ORIGINAL CONTRIBUTION

B vitamins deficiency and decreased anti-oxidative state in patients with liver cancer

ORIGINAL CONTRIBUTION

Effects of pre- and postnatal protein deprivation on atrial natriuretic peptide- (ANP-) granules of the right auricular cardiocytes

ORIGINAL CONTRIBUTION

Development of a model for optimal food fortification: vitamin D among adults in Finland

ORIGINAL CONTRIBUTION

Dietary flavones suppresses IgE and Th2 cytokines in OVA-immunized BALB/c mice

ORIGINAL CONTRIBUTION

Effect of pomegranate (Punica granatum) juice intake on hepatic oxidative stress
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits